Trial
NCT06171152
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
Early Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
—
Condition
Multiple Sclerosis
Intervention
Liraglutide Pen Injector [Saxenda]
Why stopped
Study pending amendment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-30